Maven Clinic

October 2026

1. 1. Maven’s current program combines metabolic and hormone care. It lists brand-name medications only and advertises broad starting prices that depend on medication, dose and insurance eligibility. The page does not reconfirm the older drug-specific quotes or $150 membership amount. Included first nutrition and strength-coaching visits do not establish that the prescribing consultation is free.

September 2026

1. 2. Company confirmed via own site (title 'Maven Clinic - The next generation of care for women and families', footer '© 2026 Maven Clinic Co.'). This is exactly the membership-vs-medication trap the brief warns about: the 'glp-1 care membership' is $150/month (first month discounted to $39 per the pricing section: 'glp-1 care membership $150 $39 / first month Then $150 /month') and covers clinician visits, two specialist consultations, dose adjustments, and side-effect management -- it explicitly does NOT include the medication ('Medication costs separate'). Medication is billed separately by the pharmacy at self-pay or insurance rates listed per product; both self-pay and insurance ('starting from') figures are recorded as separate price entries per drug/form, labeled accordingly, per the insurance-vs-cash-price rule. 'Foundayo' is described only as 'Oral GLP-1 pill' with no active ingredient named on any page checked, so it was classified as unspecified GLP-1 rather than assumed to be semaglutide. The Zepbound Pen self-pay price is printed as an open-ended '$1,000+/mo' (not a fixed number); recorded perMonth as the floor value with the exact quote showing it is open-ended. No explicit state-availability list or cancellation policy was found on the marketing pages checked (the GLP-1 safety-information legal page is JavaScript-rendered and returned no text).